| |
PRZOOM - /newswire/ -
Salt Lake City, UT, United States, 2011/04/26 - Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3 at the meeting - Aciont.com.
|
| |
|
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Aciont Inc. announced today that the company will present findings on the ocular iontophoresis of macromolecules at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, FL. Iontophoresis is a minimally invasive means to deliver drugs through tissue using a mild electrical current. “A number of research publications (in the transscleral iontophoresis area) are focusing on scleral tissue. This study reveals the importance of conjunctiva in ocular drug delivery, particularly when attempting to use in vitro results to predict the outcome of in vivo transscleral iontophoresis,” said Dr. Kongnara Papangkorn, Aciont’s Director of Research.
The lead author of the presentation is Dr. Sarah A. Molokhia who works with the John A. Moran Eye Center at The University of Utah. The poster A497 is titled “Importance of the Conjunctiva in Transscleral Iontophoresis,” and can be viewed on Tuesday May 3, 2011 from 1:45 – 3:30PM in Hall B/C at the Greater Fort Lauderdale Convention Center. Aciont personnel will be in attendance at the ARVO meeting to respond to questions regarding Aciont’s work.
Aciont, Inc. (aciont.com) is a specialty biopharmaceutical company endeavoring to become the world leader in commercializing localized, non-invasive (topical passive diffusion-based and iontophoretic), controlled and sustained release back of the eye therapeutics for sight threatening diseases such as severe uveitis, diabetic macular edema and age-related macular degeneration. Aciont’s goal is to provide ophthalmologists substantially greater freedom in treating and/or preventing chronic eye diseases through optimal drug dosing and improved patient/physician compliance. Aciont is located in Salt Lake City, Utah.
|
| |
 |
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Agency / Source: Aciont, Inc.
|
| |
|
| |
Availability: All Regions (Including Int'l)
|
| |
Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker
|
| |
Distribution / Indexing: [+]
|
| |
|
| |
# # #
|
| |
|
| |
|
| |
Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!
Company website links NOT available to basic submissions |
|
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source. |
| |
|
| |
For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Aciont.com
| |
Contact: Jillian Conrad - Aciont.com
801-359-3461  admin[.]aciont.com
|
